Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Vizsgálati helyszín

Rajavithi Hospital

Bangkok, 10400, ThaiföldMég nincs intézményhez kötve

19futó vizsgálat
16lezárt vizsgálat

Az itteni vizsgálatok

Miről szól a helyszín 35 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek: 2-es típusú cukorbetegség5 vizsgálat
Áttétes emlőrák5 vizsgálat
Tüdőrák4 vizsgálat
Elhízás3 vizsgálat
Gyomor- és nyelőcsőrák3 vizsgálat
Arthritis psoriatica2 vizsgálat
Lupus (SLE)2 vizsgálat
Máj- és epeúti rák2 vizsgálat
Peripheral artery disease2 vizsgálat
Pikkelysömör2 vizsgálat
Stroke (szélütés)2 vizsgálat
Gout1 vizsgálat
és még 11
Fázis: 3. fázis26 vizsgálat
2. fázis2 vizsgálat
Állapot: Lezárult14 vizsgálat
Fut, nem toboroz11 vizsgálat
Toboroz6 vizsgálat
Meghívásos bevonás1 vizsgálat
Még nem toboroz1 vizsgálat
Leállították1 vizsgálat
Visszavonták1 vizsgálat
Fő szponzor: Hoffmann-La Roche12 vizsgálat
Novo Nordisk A/S4 vizsgálat
Department of Medical Services Ministry of Public Health of Thailand3 vizsgálat
Concept Medical Inc.2 vizsgálat
Janssen Research & Development, LLC2 vizsgálat
és még 11

Futó vizsgálatok

Toboroz
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
NCT07351058· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
NCT06847542· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT06757634· 3. fázis· Celcuity Inc· Forrás
Contact: Nadene Zack, MS
Toboroz
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT06499285· 3. fázis· Takeda· Forrás
Contact: Kunapa Iam-arunthai (principal investigator)
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis
NCT06878404· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
NCT06807424· 3. fázis· Janssen Research & Development, LLC· Forrás
Meghívásos bevonás
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
NCT06475742· 3. fázis· Viatris Innovation GmbH· Forrás
Toboroz
COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2
NCT06396299· Mahidol University· Forrás
Contact: Pontawee Kaewcomdee, B.N.S
Fut, nem toboroz
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
NCT06065748· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
NCT05648500· 3. fázis· Viatris Innovation GmbH· Forrás
Fut, nem toboroz
A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
NCT05170204· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
NCT05296798· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495· 3. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
NCT04576455· 2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
NCT04546009· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
NCT04511234· Concept Medical Inc.· Forrás
Contact: Supachai Chanvitan, Dr.
Toboroz
SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease
NCT04511247· Concept Medical Inc.· Forrás
Contact: Supachai Chanvitan, Dr.
Fut, nem toboroz
Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals
NCT03042754· The HIV Netherlands Australia Thailand Research Collaboration· Forrás
Fut, nem toboroz
Rajavithi Health Promotion Project (Population Base Cohort)
NCT00368095· Department of Medical Services Ministry of Public Health of Thailand· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Lezárt vizsgálatok

Visszavonták
Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
NCT06083675· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
NCT05813912· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
NCT05586971· 3. fázis· LG Chem· Forrás
Lezárult
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
NCT05394519· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
Efficacy of NAC for the Prevention and Relief of PIPN in Women With Ovarian, Tubal, and Peritoneal Cancer
NCT05539053· Department of Medical Services Ministry of Public Health of Thailand· Forrás
Lezárult
Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
NCT05052801· 3. fázis· Amgen· Forrás
Lezárult
Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
NCT04732494· 2. fázis· BeiGene· Forrás
Leállították
Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements
NCT04093362· 3. fázis· Taiho Oncology, Inc.· Forrás
Lezárult
A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma
NCT04540211· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
Comparison of Serum Calcium Level Between Preoperative Vitamin D and Non-vitamin D Regimen of Total Parathyroidectomy in End-stage Renal Failure Patients in Rajavithi Hospital
NCT04967469· Department of Medical Services Ministry of Public Health of Thailand· Forrás
Lezárult
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
NCT04513925· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation
NCT04102098· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
NCT03914326· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT03735121· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT02838420· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
NCT02003924· 3. fázis· Pfizer· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 14.

Építés alatt, nem éles – Rajavithi Hospital: vizsgálati helyszín – Frontlight Research